Progyny, Inc. (PGNY) |
|
35.225 -1.855 (-5%)
|
02-03 14:41 |
|
Open: |
36.13 |
Pre. Close: |
37.08 |
|
High:
|
36.55 |
Low:
|
35 |
|
Volume:
|
476,212 |
Market Cap:
|
3,272(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 2:19:20 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 43.36 One year: 50.65 |
| Support: |
Support1: 31.5 Support2: 28.03 |
| Resistance: |
Resistance1: 37.13 Resistance2: 43.36 |
| Pivot: |
33.93  |
| Moving Average: |
MA(5): 35.07 MA(20): 33.16
MA(100): 35.81 MA(250): 37.1 |
| MACD: |
MACD(12,26): 0.8 Signal(9): 0.4 |
| Stochastic oscillator: |
%K(14,3): 86.5 %D(3): 88.7 |
| RSI: |
RSI(14): 59.1 |
| 52-week: |
High: 53.09 Low: 25.67 |
| Average Vol(K): |
3-Month: 828 (K) 10-Days: 647 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PGNY ] has closed below upper band by 18.6%. Bollinger Bands are 34.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
37.17 - 37.32 |
37.32 - 37.46 |
|
Low:
|
35.12 - 35.29 |
35.29 - 35.46 |
|
Close:
|
36.8 - 37.07 |
37.07 - 37.33 |
|
Company Description |
|
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. |
Headline News |
Thu, 02 Feb 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY - Benzinga
Thu, 02 Feb 2023
Eagle Asset Management Inc. Has $15.74 Million Stock Holdings in ... - MarketBeat
Tue, 31 Jan 2023
SG Americas Securities LLC sells shares of Progyny, Inc. (NASDAQ ... - Best Stocks
Mon, 30 Jan 2023
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings ... - Nasdaq
Wed, 25 Jan 2023
Crossmark Global Holdings Inc. Invests $231000 in Progyny, Inc ... - MarketBeat
Mon, 23 Jan 2023
Progyny, Inc. is sold by the State of New Jersey Common Pension ... - Best Stocks
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Health Information Services |
| Shares Out. |
90 (M) |
| Shares Float |
74 (M) |
|
% Held by Insiders
|
1.3 (%) |
|
% Held by Institutions
|
96.7 (%) |
|
Shares Short
|
5,580 (K) |
|
Shares Short P.Month
|
4,490 (K) |
Stock Financials |
|
EPS
|
0.91 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
2.49 |
|
Profit Margin (%)
|
7.3 |
|
Operating Margin (%)
|
2.8 |
|
Return on Assets (ttm)
|
2.8 |
|
Return on Equity (ttm)
|
17.6 |
|
Qtrly Rev. Growth
|
51.5 |
|
Gross Profit (p.s.)
|
1.24 |
|
Sales Per Share
|
6.82 |
|
EBITDA (p.s.)
|
0.2 |
|
Qtrly Earnings Growth
|
-52.6 |
|
Operating Cash Flow
|
41 (M) |
|
Levered Free Cash Flow
|
37 (M) |
Stock Valuations |
|
PE Ratio
|
38.8 |
|
PEG Ratio
|
8.5 |
|
Price to Book value
|
14.18 |
|
Price to Sales
|
5.17 |
|
Price to Cash Flow
|
77.96 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
